Nasonex Nasal Spray
Company: Schering-Plough
Approval Status: Approved January 1999
Treatment for: Immunology/Allergy
General Information
Other Useful Resources
Nasonex has been approved for the prophylaxis and treatment of the nasal symptoms of seasonal allergic rhinitis and the treatment of the nasal symptoms of perennial allergic rhinitis, in adults and children 12 years of age and older.
The FDA drug information shown here is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.
